Skip to main content
Equibles
IMNM logo

IMNM · Immunome Inc. · Metrics

Track IMNM — free

Use IMNM with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IMNM.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$18.17 +0.25 (+1.37%)
Russell 2000 member Rebalance outlook locked
Market Cap
$2.04B
Shares
113.58M
Volume · Oct 21 69.61K Avg daily vol (3M) 1.23M

IMNM metrics

73 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$17.92
Market cap
$2.04B

Price action

20 metrics
Price change (1W)
+1.9%
Price change (30D)
-28.5%
Price change (3M)
-21.3%
Price change (6M)
-24.9%
Price change (YTD)
-16.6%
Price change (1Y)
+10.3%
Trailing year
Price change (5Y)
-3.1%
52-week high
$29.83
52-week low
$15.24
Change from 52-week high
-39.9%
Change from 52-week low
+17.6%
Annualized volatility
61.6%
Annualized volatility (3M)
56.9%
Beta
1.7
RSI (14D)
34.4
Price vs SMA 50
-25.1%
Price vs SMA 200
-20.6%
Avg volume (3M)
1.23M
Relative volume
1.7
Average dollar volume
$28.96M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
113.58M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
3.9
reciprocal yield 25.8%
FCF yield
-10.8%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-12.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
129.5×
reciprocal yield 0.8%
EV / revenue historical average (5Y)
129.5×
reciprocal yield 0.8%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$270.46M
Net income (TTM)
−$254.32M
Trailing 12 months
Diluted EPS (TTM)
$-2.54
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.00
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-2.67
EBITDA per diluted share (TTM)
$-2.64
Net income per diluted share (TTM)
$-2.51
Operating cash flow per diluted share (TTM)
$-2.03
Free cash flow per diluted share (TTM)
$-2.13
Capital expenditures per diluted share (TTM)
$0.10
R&D per diluted share (TTM)
$2.03
Stock compensation per diluted share (TTM)
$0.31
Book value per share
$5.61

Growth

11 metrics
Revenue growth YoY
-100.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$0
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+30.2%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-48.4%
Return on assets
-45.0%
Debt / equity
0.0
Current ratio
15.1
EBITDA (TTM)
−$267.69M
Free cash flow (TTM)
−$219.09M
Quick ratio
15.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$217.71M
Latest balance sheet
Cash & equivalents
$217.71M
Total assets
$565.38M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$208.79M
Capital expenditures (TTM)
$10.29M
R&D (TTM)
$206.23M
SG&A (TTM)
—
Stock compensation (TTM)
$31.39M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
203
13F filer change QoQ
0
Institutional ownership
104.3%
Conviction holders (share of 13F filers)
2.5%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+0.3%
Holder tenure
9.7
Price vs estimated holder cost
+35.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
15.1%

Short interest

3 metrics
Short interest
14.8%
Latest settlement · 9.9 days to cover
Days to cover
9.9d
Short-squeeze score
70 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$5.75M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1472012 CUSIP 45257U108 13F (30d) 11 filings 11 filers Visit website Investor relations